As of Jul 02
| +0.17 / +0.86%|
The 1 analysts offering 12-month price forecasts for Albany Molecular Research Inc have a median target of 22.00, with a high estimate of 22.00 and a low estimate of 22.00. The median estimate represents a +10.44% increase from the last price of 19.92.
The current consensus among 2 polled investment analysts is to Buy stock in Albany Molecular Research Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.